Almirall SA 2010 AR2
The report highlights Almirall's performance in 2010, achieving financial targets in a challenging environment with net sales of ‐882.4 million. The company made significant progress in its R&D pipeline, successfully completing Phase III trials for aclidinium bromide and linaclotide. Almirall expanded its international presence, with international sales accounting for 44% of the total. Additionally, the company demonstrated its social commitment through employee training, occupational hazard prevention, and environmental initiatives, including the renewal of its ISO 14001 certification.
Company: Almirall SA
Sector: Manufacturing
Country: Spain
Year: 2010
Type: AR2
Pages: 111
Back to company
Almirall SA
Annual Report
The report highlights Almirall's performance in 2010, achieving financial targets in a challenging environment with net sales of ‐882.4 million. The company made significant progress in its R&D pipeline, successfully completing Phase III trials for aclidinium bromide and linaclotide. Almirall expanded its international presence, with international sales accounting for 44% of the total. Additionally, the company demonstrated its social commitment through employee training, occupational hazard prevention, and environmental initiatives, including the renewal of its ISO 14001 certification.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2010
Reporting Period
Jan 1, 2010 - Dec 31, 2010
Fiscal Year
2010
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees